{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:00:06Z","timestamp":1794862806302,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T00:00:00Z","timestamp":1309219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10875-011-9561-3","type":"journal-article","created":{"date-parts":[[2011,6,28]],"date-time":"2011-06-28T05:36:16Z","timestamp":1309239376000},"page":"773-777","source":"Crossref","is-referenced-by-count":25,"title":["Monozygotic Twin Pair Showing Discordant Phenotype for X-linked Thrombocytopenia and Wiskott\u2013Aldrich Syndrome: a Role for Epigenetics?"],"prefix":"10.1007","volume":"31","author":[{"given":"David","family":"Buchbinder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,28]]},"reference":[{"key":"9561_CR1","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.jaci.2009.07.053","volume":"125","author":"LD Notarangelo","year":"2010","unstructured":"Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S182\u201394.","journal-title":"J Allergy Clin Immunol"},{"key":"9561_CR2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1525-1578(10)60493-X","volume":"6","author":"MS Lim","year":"2004","unstructured":"Lim MS, Elenitoba-Johnson K. The molecular pathology of primary immunodeficiencies. J Mol Diagn. 2004;6:59\u201383.","journal-title":"J Mol Diagn"},{"key":"9561_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2002.tb04911.x","volume":"981","author":"M Morange","year":"2002","unstructured":"Morange M. The relations between genetics and epigenetics: a historical point of view. Ann N Y Acad Sci. 2002;981:50\u201360.","journal-title":"Ann N Y Acad Sci"},{"key":"9561_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4161\/epi.1.2.2762","volume":"1","author":"R Holiday","year":"2006","unstructured":"Holiday R. Epigenetics: a historical overview. Epigenetics. 2006;1:76\u201380.","journal-title":"Epigenetics"},{"key":"9561_CR5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","volume":"120","author":"RS Geha","year":"2007","unstructured":"Geha RS, Notarangelo LD, Casanova J-L, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776\u201394.","journal-title":"J Allergy Clin Immunol"},{"key":"9561_CR6","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1172\/JCI26956","volume":"115","author":"RH Buckley","year":"2005","unstructured":"Buckley RH. Variable phenotypic expression of mutations in genes of the immune system. J Clin Invest. 2005;115:2974\u20136.","journal-title":"J Clin Invest"},{"key":"9561_CR7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/cmi.2010.78","volume":"8","author":"F Meda","year":"2011","unstructured":"Meda F, Folci M, Baccarelli A, et al. The epigenetics of autoimmunity. Cell Mol Immunol. 2011;8:226\u201336.","journal-title":"Cell Mol Immunol"},{"key":"9561_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaut.2009.03.007","volume":"33","author":"A Hewagama","year":"2009","unstructured":"Hewagama A, Richardson B. The genetics and epigenetics of autoimmune disease. J Autoimmun. 2009;33:3\u201311.","journal-title":"J Autoimmun"},{"key":"9561_CR9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/08916930802024202","volume":"41","author":"M Erlich","year":"2008","unstructured":"Erlich M, Sanchez C, Shao C, et al. ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity. 2008;41:253\u201371.","journal-title":"Autoimmunity"},{"key":"9561_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1521-6616(03)00201-8","volume":"109","author":"M Erlich","year":"2003","unstructured":"Erlich M. The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol. 2003;109:17\u201328.","journal-title":"Clin Immunol"},{"key":"9561_CR11","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","volume":"113","author":"M Bosticardo","year":"2009","unstructured":"Bosticardo M, Marangoni F, Aiuti A, et al. Recent advances in understanding the pathophysiology of Wiskott\u2013Aldrich syndrome. Blood. 2009;113:6288\u201395.","journal-title":"Blood"},{"key":"9561_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbmt.2008.10.007","volume":"15","author":"HD Ochs","year":"2009","unstructured":"Ochs HD, Filipovich AH, Veys P, et al. Wiskott\u2013Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant. 2009;15:84\u201390.","journal-title":"Biol Blood Marrow Transplant"},{"key":"9561_CR13","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1182\/blood-2009-09-239087","volume":"115","author":"MH Albert","year":"2010","unstructured":"Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010;115:3231\u20138.","journal-title":"Blood"},{"key":"9561_CR14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.molimm.2010.11.013","volume":"48","author":"V Gulacsy","year":"2011","unstructured":"Gulacsy V, Freiberger T, Shcherbina A, et al. Genetic characteristics of eighty-seven patients with the Wiskott\u2013Aldrich syndrome. Mol Immunol. 2011;48:788\u201392.","journal-title":"Mol Immunol"},{"key":"9561_CR15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/bcmd.1999.0247","volume":"25","author":"LJ Thompson","year":"1999","unstructured":"Thompson LJ, Lalloz M, Layton DM. Unique and recurrent WAS gene mutation in Wiskott\u2013Aldrich syndrome and X-linked thrombocytopenia. Blood Cells Mol Dis. 1999;25:218\u201326.","journal-title":"Blood Cells Mol Dis"},{"key":"9561_CR16","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood.V90.7.2680","volume":"90","author":"Q Zhu","year":"1997","unstructured":"Zhu Q, Watanabe C, Liu T, et al. Wiskott\u2013Aldrich syndrome\/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 1997;90:2680\u20139.","journal-title":"Blood"},{"key":"9561_CR17","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-05-1592","volume":"104","author":"Y Jin","year":"2004","unstructured":"Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott\u2013Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype\/genotype correlation. Blood. 2004;104:4010\u20139.","journal-title":"Blood"},{"key":"9561_CR18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2003-05-1480","volume":"103","author":"K Imai","year":"2004","unstructured":"Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456\u201364.","journal-title":"Blood"},{"key":"9561_CR19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s004390050162","volume":"98","author":"D Schindelhauer","year":"1996","unstructured":"Schindelhauer D, Weiss M, Hellebrand H, et al. Wiskott\u2013Aldrich syndrome: no strict genotype\u2013phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet. 1996;98:68\u201376.","journal-title":"Hum Genet"},{"key":"9561_CR20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajmg.1228","volume":"100","author":"C Fillat","year":"2001","unstructured":"Fillat C, Espanol T, Oset M, et al. Identification of WASP mutations in 14 Spanish families with Wiskott\u2013Aldrich syndrome. Am J Med Genet. 2001;100:116\u201321.","journal-title":"Am J Med Genet"},{"key":"9561_CR21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clim.2008.12.006","volume":"131","author":"GP Yu","year":"2009","unstructured":"Yu GP, Chiang D, Song SJ, et al. Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol. 2009;131:240\u201353.","journal-title":"Clin Immunol"},{"key":"9561_CR22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clim.2008.08.006","volume":"129","author":"KC Nadeau","year":"2008","unstructured":"Nadeau KC, Callejas A, Wong WB, et al. Idiopathic neutropenia of childhood is associated with Fas\/FasL expression. Clin Immunol. 2008;129:438\u201347.","journal-title":"Clin Immunol"},{"key":"9561_CR23","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jaci.2008.11.037","volume":"123","author":"KD Nguyen","year":"2009","unstructured":"Nguyen KD, Vanichsarn C, Fohner A, et al. Selective deregulation in chemokine signaling pathways of CD4 + CD25(hi)CD127(lo)\/(\u2212) regulatory T cells in human allergic asthma. J Allergy Clin Immunol. 2009;123:933\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"9561_CR24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1445-5994.1988.tb02247.x","volume":"18","author":"K Forsyth","year":"1988","unstructured":"Forsyth K, Seshadri R, Matthews C, Heddle R. Wiskott\u2013Aldrich in identical twins: abnormality of CD4 and CD8 positive lymphocytes. Aust NZ J Med. 1988;18:73\u20136.","journal-title":"Aust NZ J Med"},{"key":"9561_CR25","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1093\/nar\/gkr017","volume":"39","author":"H Xie","year":"2011","unstructured":"Xie H, Wang M, de Andrade A, et al. Genome-wide quantitative assessment of variation in DNA methylation patterns. Nucleic Acids Res. 2011;39:4099\u2013108.","journal-title":"Nucleic Acids Res"},{"key":"9561_CR26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1101\/gr.969603","volume":"13","author":"T Ushijima","year":"2003","unstructured":"Ushijima T, Watanabe N, Okochi E, et al. Fidelity of the methylation pattern and its variation in the genome. Genome Res. 2003;13:868\u201374.","journal-title":"Genome Res"},{"key":"9561_CR27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.0105-2896.2006.00399.x","volume":"211","author":"EL Pearce","year":"2006","unstructured":"Pearce EL. Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection. Immunol Rev. 2006;211:197\u2013202.","journal-title":"Immunol Rev"},{"key":"9561_CR28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000314077","volume":"2","author":"CE McCall","year":"2010","unstructured":"McCall CE, Yoza B, Liu T, et al. Gene-specific epigenetic regulation in serious infections with systemic inflammation. J Innate Immun. 2010;2:395\u2013405.","journal-title":"J Innate Immun"},{"key":"9561_CR29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.mehy.2008.10.039","volume":"73","author":"AB Csoka","year":"2009","unstructured":"Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses. 2009;73:770\u201380.","journal-title":"Med Hypotheses"},{"key":"9561_CR30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cbpa.2010.06.174","volume":"14","author":"RA Copeland","year":"2010","unstructured":"Copeland RA, Olhava EJ, Scott MP. Targeting epigenetic enzymes for drug discovery. Curr Opin Chem Biol. 2010;14:505\u201310.","journal-title":"Curr Opin Chem Biol"},{"key":"9561_CR31","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/jnci\/djj447","volume":"98","author":"GS Mack","year":"2006","unstructured":"Mack GS. Epigenetic cancer therapy makes headway. JNCI. 2006;98:1443\u20134.","journal-title":"JNCI"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9561-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-011-9561-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-011-9561-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T22:18:36Z","timestamp":1592691516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-011-9561-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,28]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9561"],"URL":"https:\/\/doi.org\/10.1007\/s10875-011-9561-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,28]]}}}